日本語 
SOLA Biosciences Japan GK, the branch of the Boston-based company SOLA Biosciences Inc. has received about ¥6 billion in support from the Japan Agency for Medical Research and Development known…
SOLA Biosciences Japan Secures ¥6B Grant for ALS Gene Therapy
SOLA Biosciences Japan GK, the branch of the Boston-based company SOLA Biosciences…
ITM and Lumara Bio Share New ITM-11 Cancer Therapy Information
ITM Isotope Technologies Munich SE (ITM) and its oncology therapeutics division, Lumara…
Siemens Healthineers Unveils Accela Radiotherapy System
Siemens Healthineers has launched Accela, a radiotherapy system that is meant to…
Personal Health Tech Teams Up With Medical Records Warehouse
Personal Health Tech Co., Ltd., which provides "Kensapo," a service that broadly…
ARIA Cybersecurity Deploys AZT PROTECT at Pharmaceutical Manufacturer
ARIA Cybersecurity, a business of CSPi, has announced a second deployment of…
Ionis and Roche Report Progress for Sefaxersen
Ionis Pharmaceuticals and Roche have revealed encouraging interim results from the Phase…
Pharming Reports Positive Phase II Data for Leniolisib
Pharming Group announced data from a Phase II clinical trial that assessed…
FACEDUO Launches New Content on Dementia Perspectives
JOLIGood Co., Ltd. has launched "Understanding a New Perspective on Dementia" as…
SOLA Biosciences Japan Secures ¥6B Grant for ALS Gene Therapy
SOLA Biosciences Japan GK, the branch of the Boston-based company SOLA Biosciences…
ITM and Lumara Bio Share New ITM-11 Cancer Therapy Information
ITM Isotope Technologies Munich SE (ITM) and its oncology therapeutics division, Lumara…
Siemens Healthineers Unveils Accela Radiotherapy System
Siemens Healthineers has launched Accela, a radiotherapy system that is meant to…
Personal Health Tech Teams Up With Medical Records Warehouse
Personal Health Tech Co., Ltd., which provides "Kensapo," a service that broadly…
ARIA Cybersecurity Deploys AZT PROTECT at Pharmaceutical Manufacturer
ARIA Cybersecurity, a business of CSPi, has announced a second deployment of…
Ionis and Roche Report Progress for Sefaxersen
Ionis Pharmaceuticals and Roche have revealed encouraging interim results from the Phase…
Pharming Reports Positive Phase II Data for Leniolisib
Pharming Group announced data from a Phase II clinical trial that assessed…
FACEDUO Launches New Content on Dementia Perspectives
JOLIGood Co., Ltd. has launched "Understanding a New Perspective on Dementia" as…
English